nach oben

Acta Diabetologica

Erschienen in:

01.06.2011 | Original Article

Changes in body weight are significantly associated with changes in fasting plasma glucose and HDL cholesterol in Japanese men without abdominal obesity (waist circumference < 85 cm)

verfasst von: Eiji Oda, Ryu Kawai

Erschienen in: Acta Diabetologica | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

The aims are to examine whether changes in body weight (dBW) are associated with changes in cardiovascular risk factors in Japanese men without abdominal obesity (waist circumference (WC) < 85 cm) and which anthropometric index, dBW or changes in WC (dWC), is more strongly associated with changes in cardiovascular risk factors in men without abdominal obesity. It is a retrospective study in 692 Japanese men without abdominal obesity who took annual health screening tests consecutively over one year. Standardized linear regression coefficients (SRCs) of dBW and dWC were calculated for changes in systolic blood pressure (dSBP), diastolic blood pressure (dDBP), fasting plasma glucose (dFPG), triglycerides (dTG), HDL cholesterol (dHDL), and high-sensitivity C-reactive protein (dCRP). The SRCs of dBW for dFPG and dHDL were significant in all men and in men with each risk factor corresponding to the component of metabolic syndrome (MetS). The SRCs of dWC for dTG and dCRP were significant in all men but not in men with each risk factor corresponding to the MetS component. In conclusions, dBW were significantly associated with dFPG and dHDL in Japanese men without abdominal obesity. Therefore, abdominal obesity should not be considered as a necessary component of MetS in Japanese men. dBW may be more useful than dWC as a marker of changes in cardiovascular risk factors in lifestyle intervention programs.

Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMedCrossRef

Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Furchart JC, James WP, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef

Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome―a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469–480PubMedCrossRef

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735–2752PubMedCrossRef

Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289–2304PubMedCrossRef

Reaven GM (2006) The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 83:1237–1247PubMed

Oda E (2008) The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 31:1283–1291PubMedCrossRef

Matsuzawa YM (1997) Pathophysiology and molecular mechanism of visceral fat syndrome: the Japanese experience. Diabetes Metab Rev 13:3–13PubMedCrossRef

The Examination Committee for Criteria of Metabolic Syndrome (2005) Definition and criteria of metabolic syndrome. J Jpn Soc Intern Med 94:794–809 (in Japanese)

10.

Oda E (2010) A review of metabolic syndrome as systemic pre-disease state developing through adipose tissue disease. Ningen Dock 24:1–6

11.

Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, Wang S, Fortier M, Greenberg AS, Obin MS (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 46:2347–2355PubMedCrossRef

12.

Katagiri H, Yamada T, Oka Y (2007) Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res 101:27–39PubMedCrossRef

13.

Kim J, Montagnani M, Koh KK, Quon MJ (2006) Reciprocal relationships between insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation 113:1888–1904PubMedCrossRef

14.

Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448–1454PubMedCrossRef

15.

Ridker PM, Wilson PWF, Grandy SM (2004) Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109:2818–2825PubMedCrossRef

16.

Rizzo M, Rizvi AA, Rini GB, Berneis K (2009) The therapeutic modulation of atherogenic dyslipidemia and inflammatory markers in the metabolic syndrome: what is the clinical relevance? Acta Diabetol 46:1–11PubMedCrossRef

17.

Buscemi S, Verga S, Cottone S, Azzolina V, Buscemi B, Gioia D, Cerasola G (2009) Glycaemic variability and inflammation in subjects with metabolic syndrome. Acta Diabetol 46:55–61PubMedCrossRef

18.

Wu CZ, Hsiao FC, Lin JD, Su CC, Wang KS, Chu YM, Lee LH, Wang K, Hsia TL, Pei D (2010) Relationship between white blood cell count and components of metabolic syndrome among young adolescents. Acta Diabetol 47:65–71PubMedCrossRef

19.

Oda E, Kawai R (2009) Very low levels of high-sensitivity C-reactive protein are not bimodaly distributed but significantly related with other metabolic risk factors in Japanese. Intern Med 48:953–958PubMedCrossRef

20.

Oda E, Kawai R (2009) Tentative cut-off point of high-sensitivity C-reactive protein for a component of metabolic syndrome in Japanese. Circ J 73:755–759PubMedCrossRef

21.

Oda E, Kawai R (2010) Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese. Intern Med 49:117–124PubMedCrossRef

22.

Oda E, Kawai R (2010) Reproducibility of high-sensitivity C-reactive protein as an inflammatory component of metabolic syndrome in Japanese. Circ J 74:1488–1493PubMedCrossRef

23.

Hara K, Matsushita Y, Horikoshi M, Yoshiike N, Yokoyama T, Tanaka H, Kadowaki T (2006) A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care 29:1123–1124PubMedCrossRef

24.

Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, Nonas C, Kahn R (2007) Waist circumference and cardiometabolic risk: a consensus statement from Shaping America’s Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 30:1647–1652PubMedCrossRef

25.

Yamada S, Tsukamoto Y, Irie J (2007) Waist circumference in metabolic syndrome. Correspondence. Lancet 370:1541–1542PubMedCrossRef

26.

Oda E, Kawai R (2010) Comparison among body mass index (BMI), waist circumference (WC), and percent body fat (%BF) as anthropometric markers for the clustering of metabolic risk factors in Japanese. Intern Med 49:1477–1482PubMedCrossRef

27.

Worachartcheewan A, Nantasenamat C, Isarankura-Na-Ayudhya C, Pidetcha P, Prachayasittikul V (2009) Lower BMI cutoff for assessing the prevalence of metabolic syndrome in Thai population. Acta Diabetol [Epub ahead of print]

28.

Wing RR, Jeffery RW, Burton LR, Thorson C, Kuller LH, Folsom AR (1992) Change in waist-hip ratio with weight loss and its association with change in cardiovascular risk factors. Am J Clin Nutr 55:1086–1092PubMed

29.

Ishizaka N, Ishizaka Y, Toda E, Koike K, Nagai R, Yamakado M (2009) Impact of changes in waist circumference and BMI over one-year period on serum lipid data in Japanese individuals. J Atheroscler Thromb 16:764–771PubMed

30.

Ruderman NB, Schneider SH, Berchtold P (1981) The “metabolically obese”, normal-weight individual. Am J Clin Nutr 34:1617–1621PubMed

31.

Kadota A, Hozawa A, Okamura T, Kadowaki T, Nakamura K, Murakami Y, Hayakawa T, Kita Y, Okayama A, Nakamura Y, Kashiwagi A, Ueshima H (2007) Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990–2000. Diabetes Care 30:1533–1538PubMedCrossRef

32.

Saito I, Iso H, Kokubo Y, Inoue M, Tsugane S (2009) Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study. Circ J 73:878–884PubMedCrossRef

33.

Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S, JPHC Study Group (2009) The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: Japan public health center-based study. Hypertens Res 32:289–298PubMedCrossRef

34.

Miyazaki M, Babazono A, Ishii T, Sugie T, Momose Y, Iwahashi M, Une H (2002) Effects of low body mass index and smoking on all-cause mortality among middle-aged and elderly Japanese. J Epidemiol 12:40–41PubMed

Titel: Changes in body weight are significantly associated with changes in fasting plasma glucose and HDL cholesterol in Japanese men without abdominal obesity (waist circumference < 85 cm)
verfasst von: Eiji Oda
Ryu Kawai
Publikationsdatum: 01.06.2011
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 2/2011
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-010-0238-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Changes in body weight are significantly associated with changes in fasting plasma glucose and HDL cholesterol in Japanese men without abdominal obesity (waist circumference < 85 cm)

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2011

Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study

Metabolic consequences of incorrect insulin administration techniques in aging subjects with diabetes

Primary hyperlipidemias in children: effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption

Metabolic syndrome and vascular risk: a 9-year follow-up among the aged in Finland

Systemic and spinal administration of etanercept, a tumor necrosis factor alpha inhibitor, blocks tactile allodynia in diabetic mice

Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin